Complement-dependent histaminase release from human granulocytes

The Journal of Clinical Investigation
J J HermanH R Colten

Abstract

The role of particle-bound complement proteins in the induction of noncytotoxic enzyme release from human granulocytes was investigated with the use of sera genetically deficient in complement and highly purified complement components. Release of histaminase, one of two important histamine catabolizing enzymes, and beta-glucuronidase from polymorphonuclear leukocytes was solely dependent on particle-bound C3b (the larger cleavage product of the third component of complement) when fluid-phase complement was excluded. The extent of enzyme release was a function of particle-bound C3b input, was reduced by exposing the particles to C3b inactivator, and was blocked by fluid-phase C3b. Phagocytosis of the C3b-coated particles was not required for enzyme release from neutrophils. In contrast, phagocytosis of "opsonized" particles was required for noncytotoxic release of histaminase and arylsulfatase from eosinophils; other proteins, as well as C3b, were able to opsonize particles for induction of enzyme release from eosinophils. These studies suggest a dual role for complement (particularly C3) in modulating vascular permeability phenomena, i.e., release of vasoactive mediators by the action of C3a and C5a, and release of the correspo...Continue Reading

References

Oct 1, 1976·The Journal of Experimental Medicine·R S ZeigerH R Colten
Jan 1, 1975·Annual Review of Biochemistry·H J Müller-Eberhard
Mar 1, 1970·Proceedings of the National Academy of Sciences of the United States of America·C A DanielsA L Notkins
Oct 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·I M GoldsteinG Weissmann
Nov 1, 1969·The Journal of Immunology : Official Journal of the American Association of Immunologists·M Ballow, C G COCHRANE
Dec 22, 1970·Biochimica Et Biophysica Acta·T Boenisch, C A Alper
Aug 1, 1965·The Journal of Experimental Medicine·U R NILSSON, H J MUELLER-EBERHARD
Aug 1, 1965·The Journal of Experimental Medicine·P A WardH J MUELLER-EBERHARD

Citations

Jan 1, 1985·Immunology Letters·Z Fishelson
Feb 20, 1987·Biochimica Et Biophysica Acta·K S RameshS H Pincus
Nov 1, 1991·The Journal of Experimental Medicine·M S MinkoffD S Silberstein
Nov 1, 1991·European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies·C M BankP J Brombacher
Dec 13, 2006·European Journal of Immunology·Sarah C Mullaly, Paul Kubes
Jun 1, 1983·European Journal of Immunology·R G MedicusM A Arnaout
Oct 1, 2020·International Journal of Immunopathology and Pharmacology·Thomas BoehmBernd Jilma

Related Concepts

Pseudo Arylsulfatase A
Complement C3b
Eosinophil
Exo-beta-D-Glucuronidase
Diaminobenzidine Oxidase
Neutrophil Band Cells
Opsonin
Phagocytosis
Zymosan

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.